Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

Recombinant Human METAP1 Protein– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

Recombinant Human METAP1 Protein

SKU: PKSH033589-50

To better serve you, we would like to discuss your specific requirement.
Please Contact Us for a quote.

Recombinant Human METAP1 Protein

 

SKU # PKSH033589
Expression Host E.coli

 

 

Description

Synonyms MAP 1, MAP1A, METAP1, MetAP 1, MetAP1A, Methionine aminopeptidase 1, Peptidase M 1
Species Human
Expression Host E.coli
Sequence Met1-Phe386
Accession P53582
Calculated Molecular Weight 43.2 kDa
Observed Molecular Weight 38-50 kDa
Tag None
Bio-activity Not validated for activity
  

 

Properties

Purity > 95 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Formulation Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 500mM NaCl, 10% Glycerol, pH 8.0.
Reconstitution Not Applicable



Background

Methionine Aminopeptidase 1 is a member of the M24 family of metalloproteases. METAP1 plays an important role in G(2)/M phase regulation of the cell cycle and may serve as a promising target for the discovery and development of new anticancer agents. METAP1 and METAP2 have different substrate specificity due to the differences in both size and shape of the active sites. The proteolytic removal of N-terminal methionine from nascent peptides is catalyzed by a family of enzymes known as methionine aminopeptidases (MetAPs) and is essential for cell growth. Inhibition of METAPs provides a novel strategy in developing anti-cancer drugs.